Zhongchao Inc

Zhongchao Inc(ZCMD)の株式分析

$0.965

+0.007 (+0.73%)終値時点

Loading chart…
高値
1.035
始値
0.946
出来高加重平均価格
0.98
出来高
91.16K
時価総額
3.23M
安値
0.946
売買代金
89.54K
EV/EBITDA(TTM)
0.00

Zhongchao Inc is a holding company primarily engaged in the provision of healthcare information, education, and training services to healthcare professionals and the public. The Company is primarily engaged in the provision of medical training and education services and assistance in patient-aid projects through MDMOOC online platform and offline formats. The MDMOOC online platform includes MDMOOC mobile application (App), MOOC Medical WeChat subscription account, and MDMOOC website. Under the MDMOOC brand, the Company provides various online and onsite health information services, healthcare education programs, and healthcare training products, consisting primarily of clinical practice training, open classes of medical topics, interactive case studies, academic conference and workshops, continuing education courses, and articles and short videos with educational healthcare content. The Company primarily operates its businesses in the domestic market.

www.mdmooc.org

AI分析 of Zhongchao Inc (ZCMD)

中立

Zhongchao Inc. (ZCMD) currently trades at $0.97, which is significantly down 99.87% year-to-date and 99.90% over the past year, indicating severe long-term underperformance. The RSI is at 30.86, suggesting it is oversold, but the forward P/E is 0, indicating no expected earnings growth. The company's gross margin is relatively strong at 55.5%, but it reported a net income loss of $733,276 in the last quarter. The main risk is the company's drastic decline in stock price, which has fallen 39.29% over the last 20 days, reflecting ongoing investor concerns about its viability. Given these factors, it is prudent to hold rather than buy at this time.

バリュエーション指標

Zhongchao Inc(ZCMD)の現在の予想PERは0.00で、5年平均は0.00です。

予想PER

大幅な割安
5年平均 P/E
0.00
現在のP/E
0.00
割高
0.00
割安
0.00

予想EV/EBITDA

大幅な割安
5年平均 EV/EBITDA
0.00
現在のEV/EBITDA
0.00
割高
0.00
割安
0.00

予想PSR

大幅な割安
5年平均 P/S
0.00
現在のP/S
0.00
割高
0.00
割安
0.00

Alphio AI による ZCMD の価格シナリオ

シナリオ価格は本年の最終月次予想レンジです。確率はモデルの固定ウェイト(25 / 50 / 25)であり、保証ではありません。

強

強気

強気 · 25%ZCMD

$1.32

シナリオ価格

基

基本

基本 · 50%ZCMD

$1.17

シナリオ価格

弱

弱気

弱気 · 25%ZCMD

$1.00

シナリオ価格

イベントタイムライン

2026-09-30 (ET)

08:30:00

Zhongchao Announces 1-for-2 Share Consolidation

2026-07-23 (ET)

09:30:00

Zhongchao Enters Agreement to Issue 4.55 Million Shares at $1.10

2026-06-25 (ET)

08:31:00

Zhongchao to Effectuate 1-for-3 Share Consolidation

2026-05-07 (ET)

14:50:00

Zhongchao Plans Best-Efforts Offering of 5.56M Units

2026-02-26 (ET)

08:50:00

Zhongchao to Effectuate 1-for-8 Share Consolidation

ニュース

ZCMD のよくある質問 — Alphio AI が回答

Zhongchao Inc is a holding company primarily engaged in the provision of healthcare information, education, and training services to healthcare professionals and the public. The Company is primarily engaged in the provision of medical training and education services and assistance in patient-aid projects through MDMOOC online platform and offline formats. The MDMOOC online platform includes MDMOOC mobile application (App), MOOC Medical WeChat subscription account, and MDMOOC website. Under the MDMOOC brand, the Company provides various online and onsite health information services, healthcare education programs, and healthcare training products, consisting primarily of clinical practice training, open classes of medical topics, interactive case studies, academic conference and workshops, continuing education courses, and articles and short videos with educational healthcare content. The Company primarily operates its businesses in the domestic market. It operates in the Academic & Educational Services sector.

Zhongchao Inc. (ZCMD) currently trades at $0.97, which is significantly down 99.87% year-to-date and 99.90% over the past year, indicating severe long-term underperformance. The RSI is at 30.86, suggesting it is oversold, but the forward P/E is 0, indicating no expected earnings growth. The company's gross margin is relatively strong at 55.5%, but it reported a net income loss of $733,276 in the last quarter. The main risk is the company's drastic decline in stock price, which has fallen 39.29% over the last 20 days, reflecting ongoing investor concerns about its viability. Given these factors, it is prudent to hold rather than buy at this time.

コミュニティ

もっと見る ↗

投稿はまだありません

登録またはログインして議論に参加

関連記事

本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。

取引を始める